Publications by Avi Kerendian

< back to bio

From Discretion to Regulation: What FDA’s Final Rule Means for Laboratory Developed Tests

[06/05/24]

Data Monitoring Committees in Clinical Trials: FDA Draft Guidance Released

[05/22/24]

Navigating the Ambiguity of the Texas Medical Board’s Proposed Rules on Emergency Abortions

[03/28/24]

Preparing for Change: After 20 Years, HHS Proposes Update to Research Misconduct Regulations 

[02/16/24]

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

[11/30/23]